Metatron Health

Botanical species · safety record

Haloxylon salicornicum

The EFSA Compendium of Botanicals holds 14 constituent measurements and 1 adverse-effect record for Haloxylon salicornicum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Haloxylon salicornicum (Moq.) Bunge ex Boiss.

14Constituent measurements
1Safety records
6Cited sources
0Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Carboline alkaloids2
  • Isoquinoline alkaloids2
  • Piperidine alkaloids2
  • Anabasine1
  • Cardiac glycosides1
  • Coumarins1
  • Norephedrine1
  • Phenylethylamines1
  • Saponins1
  • Synephrine1

Plant parts

  • Aerial part of plants11
  • Flower3
  • Unspecified1

Preparations

  • Solvent extraction14

Effect types

  • Digestive1

Target tissues

  • Digestive1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
SynephrineAerial part of plantsSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
AnabasineFlowerSolvent extraction—GC-MSNo resolvable identifier
Carboline alkaloidsAerial part of plantsSolvent extraction—Nuclear Magnetic Resonance (NMR)No resolvable identifier
Carboline alkaloidsAerial part of plantsSolvent extraction—UnspecifiedNo resolvable identifier
Cardiac glycosidesAerial part of plantsSolvent extraction—Phytochemical screeningNo resolvable identifier
CoumarinsAerial part of plantsSolvent extraction—UnspecifiedNo resolvable identifier
Isoquinoline alkaloidsAerial part of plantsSolvent extraction—UnspecifiedNo resolvable identifier
Isoquinoline alkaloidsAerial part of plantsSolvent extraction—Nuclear Magnetic Resonance (NMR)No resolvable identifier
NorephedrineFlowerSolvent extraction—GC-MSNo resolvable identifier
PhenylethylaminesAerial part of plantsSolvent extraction—UnspecifiedNo resolvable identifier
Piperidine alkaloidsFlowerSolvent extraction—GC-MSNo resolvable identifier
Piperidine alkaloidsAerial part of plantsSolvent extraction—UnspecifiedNo resolvable identifier
SaponinsAerial part of plantsSolvent extraction—Phytochemical screeningNo resolvable identifier
TanninsAerial part of plantsSolvent extraction—Phytochemical screeningNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
DigestiveDigestiveUnspecified—House mouse (as animal)Acute toxicityNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Michel, Karl H., Sandberg, Finn., Haglid, Frank., Norin, Torbjorn. Alkaloids of Haloxylon salicornicum. Acta Pharmaceutica Suecica, 1967, p. 97-116.
  2. Bouzidi, N., Merah, B., Derdour, A., Bellahouel, S., Benziane, M., Younos, C., Soulimani, R. Hypoglycemic and antihyperglycemic effects of Haloxylon articulatum (Forssk) Moq . Planta medica, 2008, vol. 74, no. 9, p. 1023-1023.
  3. El-Shazly, Assem., Wink, Michael. Tetrahydroisoquinoline and beta-carboline alkaloids from Haloxylon articulatum (Cav.) Bunge (Chenopodiaceae). Zeitschrift fuer naturforschung, c: journal of biosciences, 2003, p. 477-480.
  4. Azizuddin., Khan, Abdul Majeed., Mustafa, Sana. An update on secondary metabolites from Haloxylon species. Journal of the chemical society of pakistan, 2013, p. 1551-1572.
  5. Aqeel Ashraf, M., Mahmood, K., Wajid, A., Kaleem Qureshi, A., Gharibreza, M. Chemical constituents of Haloxylon salicornicum plant from Cholistan Desert, Bahawalpur, Pakistan. Journal of Food, Agriculture and Environment, 2013, vol. 11, no. 3-4, p. 1176-1182.
  6. Saleem, Nabila H., Ferro, Valerie A., Simpson, Ann M., Igoli, John., Gray, Alexander I., Drummond, Robert M. The Inhibitory Effect of Haloxylon salicornicum on Contraction of the Mouse Uterus. . Evidence-based complementary and alternative medicine : ecam, 2013, vol. 2013, p. 714075. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature

Europe PMC

Every record indexed for this species, resolvable and re-runnable.

All species

Substance index

Search and browse every species this world holds under source and hash.

Before anything else

Safety Centre

Interactions, contraindications and the escalation boundary this world does not cross.

In its own terms

Traditions

How the living traditions approach preparation, use and context.